Long-Term Efficacy and Safety of Atazanavir/Ritonavir Treatment in a Real-Life Cohort of Treatment-Experienced Patients With HIV Type 1 Infection

AIDS Research and Human Retroviruses - United States
doi 10.1089/aid.2012.0092
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

Pharmacokinetics of Etravirine Combined With Atazanavir/Ritonavir and a Nucleoside Reverse Transcriptase Inhibitor in Antiretroviral Treatment-Experienced, HIV-1-Infected Patients

AIDS Research and Treatment
ImmunologyPublic HealthAllergyEnvironmentalDermatologyInfectious DiseasesOccupational Health
2015English

Long-Term Safety and Effectiveness of Lopinavir/Ritonavir in Antiretroviral-Experienced HIV-1-infected Children

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
2010English

Real-Life Study of Dual Therapy Based on Dolutegravir and Ritonavir-Boosted Darunavir in HIV-1-infected Treatment-Experienced Patients

PLoS ONE
Multidisciplinary
2019English

Genotypic Susceptibility Scores and HIV Type 1 RNA Responses in Treatment-Experienced Subjects With HIV Type 1 Infection

AIDS Research and Human Retroviruses
VirologyInfectious DiseasesImmunology
2008English

Lopinavir/Ritonavir in the Treatment of HIV-1 Infection: A Review

Therapeutics and Clinical Risk Management
2008English

Cost-Effectiveness of Atazanavir/Ritonavir Against Lopinavir/Ritonavir in the Treatment of People Living With Hiv in Peru

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Two-Year Safety and Virologic Efficacy of Maraviroc in Treatment-Experienced Patients With CCR5-Tropic HIV-1 Infection: 96-Week Combined Analysis of MOTIVATE 1 and 2

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2010English

A Real-Life Data on the Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir +Ribavirin in Patients With Genotype 1 Chronic Hepatitis C Virus Infection in Serbia

Vojnosanitetski Pregled
MedicinePharmacology
2019English

Efficacy and Safety of Long-Term Treatment With Lenalidomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma

Blood Cancer Journal
OncologyHematology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy